Company / Profit Margin
Bone Biologics Corp Profit Margin History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-0.3%
FY2020
5-year range
-1.6% / -0.3%
FY2017-FY2020
Trend
+22.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has increased for 3 consecutive years, from -1.6% in FY2017 to -0.3% in FY2020.
Based on SEC 10-K filings.
-0.3% in FY2020 with a 3-year CAGR of +1.3%.
Improved from -0.7% to -0.3% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +1.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Bone Biologics Corp's profit margin has grown for 3 consecutive years.
- In FY2020, profit margin increased 22.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -0.3% | +22.0% |
| FY2019 | -0.4% | +37.9% |
| FY2018 | -0.7% | +58.5% |
| FY2017 | -1.6% | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026